应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DNLI Denali Therapeutics Inc.
交易中 12-23 12:50:01 EST
20.87
-0.58
-2.70%
最高
21.44
最低
20.75
成交量
21.14万
今开
21.41
昨收
21.45
日振幅
3.19%
总市值
30.04亿
流通市值
27.15亿
总股本
1.44亿
成交额
443.67万
换手率
0.16%
流通股本
1.30亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.00%报22.06美元
市场透视 · 12-19
Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.00%报22.06美元
Denali Therapeutics Inc.盘中异动 大幅上涨5.05%
市场透视 · 12-17
Denali Therapeutics Inc.盘中异动 大幅上涨5.05%
Denali Therapeutics Inc.盘中异动 早盘股价大涨5.02%报24.49美元
市场透视 · 12-06
Denali Therapeutics Inc.盘中异动 早盘股价大涨5.02%报24.49美元
Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.11%
市场透视 · 12-04
Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.11%
Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.00%报30.00美元
市场透视 · 11-13
Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.00%报30.00美元
Denali Therapeutics Inc.盘中异动 早盘大幅上涨5.20%
市场透视 · 11-11
Denali Therapeutics Inc.盘中异动 早盘大幅上涨5.20%
Denali Therapeutics Inc.2024财年第三财季实现净利润-1.07亿美元,同比减少7.70%
市场透视 · 11-09
Denali Therapeutics Inc.2024财年第三财季实现净利润-1.07亿美元,同比减少7.70%
Denali Therapeutics Inc.盘中异动 股价大涨5.10%报29.06美元
市场透视 · 11-06
Denali Therapeutics Inc.盘中异动 股价大涨5.10%报29.06美元
Denali Therapeutics Inc.盘中异动 早盘股价大涨5.01%报27.26美元
市场透视 · 11-01
Denali Therapeutics Inc.盘中异动 早盘股价大涨5.01%报27.26美元
Denali Therapeutics Inc.盘中异动 股价大涨5.01%报27.46美元
市场透视 · 10-28
Denali Therapeutics Inc.盘中异动 股价大涨5.01%报27.46美元
Denali Therapeutics Inc.盘中异动 急速下挫5.00%
市场透视 · 10-22
Denali Therapeutics Inc.盘中异动 急速下挫5.00%
Denali Therapeutics Inc.盘中异动 早盘股价大涨5.01%报27.03美元
市场透视 · 10-11
Denali Therapeutics Inc.盘中异动 早盘股价大涨5.01%报27.03美元
丹纳利-赛诺菲取消多发性硬化症药物中期研究
路透中文 · 10-11
丹纳利-赛诺菲取消多发性硬化症药物中期研究
Denali Therapeutics Inc.盘中异动 大幅下跌5.06%报27.18美元
市场透视 · 10-07
Denali Therapeutics Inc.盘中异动 大幅下跌5.06%报27.18美元
Denali Therapeutics Inc.盘中异动 急速上涨5.14%
自选股智能写手 · 08-16
Denali Therapeutics Inc.盘中异动 急速上涨5.14%
Denali Therapeutics Inc.盘中异动 股价大跌9.24%报19.85美元
自选股智能写手 · 08-05
Denali Therapeutics Inc.盘中异动 股价大跌9.24%报19.85美元
Denali Therapeutics Inc 预计每股亏损63美分 - 财报前瞻
Reuters · 08-02
Denali Therapeutics Inc 预计每股亏损63美分 - 财报前瞻
Denali Therapeutics Inc.盘中异动 股价大跌5.01%
自选股智能写手 · 08-02
Denali Therapeutics Inc.盘中异动 股价大跌5.01%
Denali Therapeutics Inc.盘中异动 股价大涨5.00%报24.79美元
自选股智能写手 · 07-26
Denali Therapeutics Inc.盘中异动 股价大涨5.00%报24.79美元
Denali Therapeutics Inc.盘中异动 下午盘急速拉升5.13%
自选股智能写手 · 07-23
Denali Therapeutics Inc.盘中异动 下午盘急速拉升5.13%
加载更多
公司概况
公司名称:
Denali Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Denali Therapeutics Inc.于2013年10月在特拉华州注册成立。他们的目标是发现和开发治疗方法来打败退化问题。神经退化代表了他们那个时代最重要的未得到满足的医疗需求之一,比如阿尔茨海默病,帕金森病疾病,肌萎缩性侧索硬化症或ALS,以及其他神经退化性疾病。这些疾病对患者和社会的负担是巨大的。他们相信现在正是他们利用强有力和雄心勃勃的努力来打败神经退化的正确时机。他们相信,他们可以在一个很少成功的领域取得了成就,因为他们拥有丰富的成功经验、热忱的科学家和药物开发者团队,他们专注的科学战略,以及他们专有的血脑屏障(BBB)平台输送技术。他们正在开发广泛的神经退行性疾病靶向治疗候选药物组合,并且最近开始了他们的第一个临床试验。他们于2015年5月开始运营。
发行价格:
--
{"stockData":{"symbol":"DNLI","market":"US","secType":"STK","nameCN":"Denali Therapeutics Inc.","latestPrice":20.87,"timestamp":1734976190974,"preClose":21.45,"halted":0,"volume":211356,"delay":0,"floatShares":130088553,"shares":143921624,"eps":-2.731484,"marketStatus":"交易中","marketStatusCode":2,"change":-0.58,"latestTime":"12-23 12:50:01 EST","open":21.41,"high":21.435,"low":20.75,"amount":4436667.215352,"amplitude":0.031935,"askPrice":20.89,"askSize":228,"bidPrice":20.85,"bidSize":461,"shortable":3,"etf":0,"ttmEps":-2.731484,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1512709200000,"adjPreClose":21.45,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":21.35,"preClose":21.45,"latestTime":"09:29 EST","volume":159,"amount":3419.1399749999996,"timestamp":1734964178112},"postHourTrading":{"tag":"盘后","latestPrice":21.45,"preClose":21.45,"latestTime":"17:03 EST","volume":622457,"amount":13351702.9805,"timestamp":1734732212976},"volumeRatio":0.250215,"impliedVol":0.7185,"impliedVolPercentile":0.5618},"requestUrl":"/m/hq/s/DNLI","defaultTab":"news","newsList":[{"id":"2492158465","title":"Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.00%报22.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492158465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492158465?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:46","pubTimestamp":1734551191,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时46分,Denali Therapeutics Inc.股票出现异动,股价大幅下挫5.00%。截至发稿,该股报22.06美元/股,成交量33.7337万股,换手率0.23%,振幅5.43%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.82%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219034631a1f944ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219034631a1f944ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNLI","LENZ","BK4139","BK4535","BK4548"],"gpt_icon":0},{"id":"2492561272","title":"Denali Therapeutics Inc.盘中异动 大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492561272","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492561272?lang=zh_cn&edition=full","pubTime":"2024-12-17 01:17","pubTimestamp":1734369441,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日01时17分,Denali Therapeutics Inc.股票出现异动,股价大幅上涨5.05%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.96%。其相关个股中,Tonix Pharmaceuticals Holding Corp.、Sagimet Biosciences Inc. - Series A、Sangamo Therapeutics, Inc.涨幅较大,Tonix Pharmaceuticals Holding Corp.、Aptevo Therapeutics Inc.、Ensysce Biosciences, Inc.较为活跃,换手率分别为312.81%、47.46%、47.12%,振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com,振幅分别为72.06%、65.83%、61.43%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011721ab7cde03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011721ab7cde03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNLI","LENZ","BK4139","BK4535","BK4548"],"gpt_icon":0},{"id":"2489723420","title":"Denali Therapeutics Inc.盘中异动 早盘股价大涨5.02%报24.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489723420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489723420?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:05","pubTimestamp":1733497534,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时05分,Denali Therapeutics Inc.股票出现波动,股价大幅上涨5.02%。截至发稿,该股报24.49美元/股,成交量2.1634万股,换手率0.02%,振幅4.72%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.54%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230535a1d981a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230535a1d981a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","DNLI","BK4535","LENZ"],"gpt_icon":0},{"id":"2488927938","title":"Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488927938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488927938?lang=zh_cn&edition=full","pubTime":"2024-12-04 03:16","pubTimestamp":1733253417,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日03时16分,Denali Therapeutics Inc.股票出现异动,股价大幅下挫5.11%。截至发稿,该股报24.32美元/股,成交量22.5859万股,换手率0.16%,振幅5.13%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.84%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204031657abf3740d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204031657abf3740d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","LENZ","DNLI","BK4548"],"gpt_icon":0},{"id":"2483093032","title":"Denali Therapeutics Inc.盘中异动 下午盘股价大跌5.00%报30.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483093032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483093032?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:08","pubTimestamp":1731434929,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时08分,Denali Therapeutics Inc.股票出现异动,股价大幅下跌5.00%。截至发稿,该股报30.00美元/股,成交量22.4431万股,换手率0.16%,振幅4.62%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.81%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113020849abbab77b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113020849abbab77b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNLI","BK4548","LENZ","BK4139","BK4535"],"gpt_icon":0},{"id":"2482369967","title":"Denali Therapeutics Inc.盘中异动 早盘大幅上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482369967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482369967?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:05","pubTimestamp":1731337538,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时05分,Denali Therapeutics Inc.股票出现异动,股价快速拉升5.20%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为457.60%、292.99%、115.94%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Bionomics Ltd Ads Each Rep 180 Ord Shs,振幅分别为83.43%、31.82%、30.43%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111230538971a5bcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111230538971a5bcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DNLI","LENZ","BK4139","BK4535","BK4548"],"gpt_icon":0},{"id":"2482485977","title":"Denali Therapeutics Inc.2024财年第三财季实现净利润-1.07亿美元,同比减少7.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482485977?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081624,"startTime":"0","endTime":"0","summary":"11月9日,Denali Therapeutics Inc.公布财报,公告显示公司2024财年第三财季净利润为-1.07亿美元,同比减少7.70%;其中营业收入为0.00美元,每股基本收益为-0.63美元。机构评级:截至2024年11月9日,当前有13家机构对Denali Therapeutics Inc.目标价做出预测,其中目标均价为41.77美元,其中最低目标价为28.00美元,最高目标价为90.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000058abae6df1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000058abae6df1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","DNLI"],"gpt_icon":0},{"id":"2481298981","title":"Denali Therapeutics Inc.盘中异动 股价大涨5.10%报29.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481298981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481298981?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903479,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分,Denali Therapeutics Inc.股票出现波动,股价急速上涨5.10%。截至发稿,该股报29.06美元/股,成交量1.144万股,换手率0.01%,振幅0.00%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.91%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223119971a4b9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223119971a4b9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","DNLI","BK4535","LENZ"],"gpt_icon":0},{"id":"2480361889","title":"Denali Therapeutics Inc.盘中异动 早盘股价大涨5.01%报27.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480361889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480361889?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:40","pubTimestamp":1730468459,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时40分,Denali Therapeutics Inc.股票出现异动,股价急速拉升5.01%。截至发稿,该股报27.26美元/股,成交量2.5999万股,换手率0.02%,振幅3.39%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.84%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121405998e4000b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121405998e4000b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","LENZ","DNLI","BK4548"],"gpt_icon":0},{"id":"2478487890","title":"Denali Therapeutics Inc.盘中异动 股价大涨5.01%报27.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478487890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478487890?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:35","pubTimestamp":1730126153,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时35分,Denali Therapeutics Inc.股票出现异动,股价快速上涨5.01%。截至发稿,该股报27.46美元/股,成交量23.6469万股,换手率0.17%,振幅4.63%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028223554971a2ae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028223554971a2ae9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4548","LENZ","DNLI","BK4139"],"gpt_icon":0},{"id":"2477813577","title":"Denali Therapeutics Inc.盘中异动 急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477813577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477813577?lang=zh_cn&edition=full","pubTime":"2024-10-22 03:36","pubTimestamp":1729539382,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日03时36分,Denali Therapeutics Inc.股票出现波动,股价急速跳水5.00%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.04%。其相关个股中,Genprex, Inc.、Gri Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃,换手率分别为10361.88%、3856.61%、1746.48%,振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为369.73%、216.60%、151.00%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022033622971a16ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022033622971a16ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","LENZ","BK4548","BK4139","DNLI"],"gpt_icon":0},{"id":"2474019582","title":"Denali Therapeutics Inc.盘中异动 早盘股价大涨5.01%报27.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474019582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474019582?lang=zh_cn&edition=full","pubTime":"2024-10-11 23:23","pubTimestamp":1728660230,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日23时23分,Denali Therapeutics Inc.股票出现异动,股价大幅上涨5.01%。截至发稿,该股报27.03美元/股,成交量15.5859万股,换手率0.11%,振幅5.52%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.96%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011232350ab6976d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011232350ab6976d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","LENZ","DNLI","BK4535"],"gpt_icon":0},{"id":"2474771111","title":"丹纳利-赛诺菲取消多发性硬化症药物中期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2474771111","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474771111?lang=zh_cn&edition=full","pubTime":"2024-10-11 04:14","pubTimestamp":1728591264,"startTime":"0","endTime":"0","summary":"丹纳利-赛诺菲取消多发性硬化症药物中期研究路透10月10日 - 药物开发商Denali Therapeutics DNLI.O周四称,其合作伙伴赛诺菲SASY.PA已终止了一项测试其治疗多发性硬化症实验药物的中期研究,因为该研究未能达到主要和次要目标。 (为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241010:nL4T3LM1JM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4548","DNLI","BK4139"],"gpt_icon":0},{"id":"2473110306","title":"Denali Therapeutics Inc.盘中异动 大幅下跌5.06%报27.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473110306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473110306?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:33","pubTimestamp":1728308000,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时33分,Denali Therapeutics Inc.股票出现异动,股价急速跳水5.06%。截至发稿,该股报27.18美元/股,成交量3.202万股,换手率0.02%,振幅1.85%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.16%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721332098e3ad7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721332098e3ad7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","LENZ","DNLI","BK4548"],"gpt_icon":0},{"id":"2459022124","title":"Denali Therapeutics Inc.盘中异动 急速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459022124","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459022124?lang=zh_cn&edition=full","pubTime":"2024-08-16 03:55","pubTimestamp":1723751734,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日03时55分,Denali Therapeutics Inc.股票出现异动,股价快速上涨5.14%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.24%。其相关个股中,Cingulate Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃,换手率分别为11446.70%、2399.97%、674.59%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cingulate Inc.、Nutriband Inc C/Wts ,振幅分别为163.33%、162.60%、115.79%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816035535ab5dde71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816035535ab5dde71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","LENZ","DNLI","BK4548"],"gpt_icon":0},{"id":"2457784837","title":"Denali Therapeutics Inc.盘中异动 股价大跌9.24%报19.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457784837","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457784837?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864731,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分,Denali Therapeutics Inc.股票出现波动,股价急速跳水9.24%。截至发稿,该股报19.85美元/股,成交量3.0992万股,换手率0.02%,振幅1.23%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.36%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213212957f2e09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213212957f2e09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","DNLI","BK4139","LENZ","BK4548"],"gpt_icon":0},{"id":"2456860892","title":"Denali Therapeutics Inc 预计每股亏损63美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456860892","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456860892?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:24","pubTimestamp":1722605041,"startTime":"0","endTime":"0","summary":" * Denali Therapeutics Inc 在公布截至2024年9月30日的财报时,预计季度收入将有所增长。* 根据LSEG的数据,12位分析师的平均预期显示,这家总部位于加利福尼亚州旧金山南部的公司的营收预计将从去年同期的127万美元增至1251.2万美元,增幅为887.5%。* LSEG 分析师对 Denali Therapeutics Inc 的平均预期为每股亏损 63 美分。* 华尔街对 Denali Therapeutics Inc 的 12 个月目标价中位数为 35.50 美元,高于其最新收盘价 23.33 美元。8月2日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNLI","LENZ"],"gpt_icon":0},{"id":"2456659455","title":"Denali Therapeutics Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456659455","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456659455?lang=zh_cn&edition=full","pubTime":"2024-08-02 00:05","pubTimestamp":1722528354,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日00时05分,Denali Therapeutics Inc.股票出现异动,股价大幅下挫5.01%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大,Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃,换手率分别为1291.40%、338.44%、208.19%,振幅较大的相关个股有Dermata Therapeutics, Inc.、Immuneering Corporation、Biomea Fusion, Inc.,振幅分别为57.55%、42.48%、40.39%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080200055596822c0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080200055596822c0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","LENZ","BK4548","BK4139","DNLI"],"gpt_icon":0},{"id":"2454802257","title":"Denali Therapeutics Inc.盘中异动 股价大涨5.00%报24.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454802257","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454802257?lang=zh_cn&edition=full","pubTime":"2024-07-26 01:07","pubTimestamp":1721927221,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日01时07分,Denali Therapeutics Inc.股票出现波动,股价快速上涨5.00%。截至发稿,该股报24.79美元/股,成交量32.8347万股,换手率0.23%,振幅5.63%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726010701aefb7b21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726010701aefb7b21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DNLI","BK4535","BK4548","LENZ"],"gpt_icon":0},{"id":"2453161857","title":"Denali Therapeutics Inc.盘中异动 下午盘急速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453161857","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453161857?lang=zh_cn&edition=full","pubTime":"2024-07-23 01:48","pubTimestamp":1721670483,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日01时48分,Denali Therapeutics Inc.股票出现异动,股价急速上涨5.13%。截至发稿,该股报22.56美元/股,成交量246.423万股,换手率1.73%,振幅6.10%。Denali Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.72%。Denali Therapeutics Inc.公司简介:Denali Therapeutics Inc是一家生物技术公司,致力于开发和探索战胜神经变性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230148039681ef03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230148039681ef03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DNLI","BK4548","LENZ","BK4535"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.denalitherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0662},{"period":"1month","weight":-0.1216},{"period":"3month","weight":-0.306},{"period":"6month","weight":-0.0521},{"period":"1year","weight":-0.0051},{"period":"ytd","weight":-0.0005}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Denali Therapeutics Inc.于2013年10月在特拉华州注册成立。他们的目标是发现和开发治疗方法来打败退化问题。神经退化代表了他们那个时代最重要的未得到满足的医疗需求之一,比如阿尔茨海默病,帕金森病疾病,肌萎缩性侧索硬化症或ALS,以及其他神经退化性疾病。这些疾病对患者和社会的负担是巨大的。他们相信现在正是他们利用强有力和雄心勃勃的努力来打败神经退化的正确时机。他们相信,他们可以在一个很少成功的领域取得了成就,因为他们拥有丰富的成功经验、热忱的科学家和药物开发者团队,他们专注的科学战略,以及他们专有的血脑屏障(BBB)平台输送技术。他们正在开发广泛的神经退行性疾病靶向治疗候选药物组合,并且最近开始了他们的第一个临床试验。他们于2015年5月开始运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.022693},{"month":2,"riseRate":0.428571,"avgChangeRate":0.015921},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.073957},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.018616},{"month":5,"riseRate":0.857143,"avgChangeRate":0.083482},{"month":6,"riseRate":0.571429,"avgChangeRate":0.06046},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.051141},{"month":8,"riseRate":0.571429,"avgChangeRate":0.06218},{"month":9,"riseRate":0.571429,"avgChangeRate":0.032087},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.060112},{"month":11,"riseRate":0.571429,"avgChangeRate":0.12875},{"month":12,"riseRate":0.428571,"avgChangeRate":0.040442}],"exchange":"NASDAQ","name":"Denali Therapeutics Inc.","nameEN":"Denali Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Denali Therapeutics Inc.(DNLI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Denali Therapeutics Inc.(DNLI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Denali Therapeutics Inc.,DNLI,Denali Therapeutics Inc.股票,Denali Therapeutics Inc.股票老虎,Denali Therapeutics Inc.股票老虎国际,Denali Therapeutics Inc.行情,Denali Therapeutics Inc.股票行情,Denali Therapeutics Inc.股价,Denali Therapeutics Inc.股市,Denali Therapeutics Inc.股票价格,Denali Therapeutics Inc.股票交易,Denali Therapeutics Inc.股票购买,Denali Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Denali Therapeutics Inc.(DNLI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Denali Therapeutics Inc.(DNLI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}